Search - tctmd.com

Displaying 61 - 80 of 104

Sort: Relevancy | Date

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Caitlin E. Cox

November 11, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Caitlin E. Cox

March 18, 2020

News Daily News

Transradial Route Gains Support as Default for Secondary TAVR Access

Yael L. Maxwell

March 02, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

Advertisement

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

COVID-19 Poised to Upend the Cath Lab, ACC and SCAI Say

Transradial Route Gains Support as Default for Secondary TAVR Access

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

FDA’s First Take on New Paclitaxel Concerns in CLI

Venous Stents: Long-term Follow-up Plus a New Contender

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

TCTMD’s Top 10 Most Popular Stories for June 2019

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content